Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 361-369
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.361
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.361
Table 1 Possible causes of infertility in men with inflammatory bowel disease
| Causes of infertility in men with IBD | Ref. |
| Surgery | [17,19-25] |
| Medications | [4,5,7,15,16,28-32,42,43] |
| Active disease | [15,16,76] |
| Poor nutrition | [15,77] |
| Alcohol use | [15,81-83] |
| Tobacco use | [15,83,86,87] |
| Psychological factor | [7,88,89] |
Table 2 Studies of sexual function after proctocolectomy in men
| Ref. | Year | No. of patients | Disease | Time since surgery | Sexual dysfunction after surgery | |
| ED | EjD | |||||
| Michelassi et al[23] | 1993 | 24 | UC | 1.5 yr (median) | 0% | 19% |
| Damgaard et al[24] | 1995 | 26 | UC | 2.8 yr (median) | 3.80% | 3.80% |
| Farouk et al[22] | 2000 | 762 | UC | 1 yr | 1% | |
| 215 | UC | 12 yr | 2% | |||
| Slors et al[17] | 2000 | 40 | Benign disease | 2.8 yr (median) | 10% | 12.50% |
| Lindsey et al[25] | 2001 | 156 | CD, UC | 6.2 yr (median) | 14% | 0% |
| Berndtsson et al[19] | 2004 | 25 | UC | 1 yr | 0% | 12% |
| Hueting et al[20] | 2004 | 35 | CD, UC | 3.5 yr (median) | 25.70% | |
| Gorgun et al[21] | 2005 | 122 | CD, UC, others | 3.6 yr (median) | 12% | 8.20% |
Table 3 Effects of medications used for inflammatory bowel disease on male fertility
| Infertility | Pregnancy complications | Recommendations | |
| Sulfasalazine | Reversible | One study | Switch to a different 5-ASA |
| Mesalazine | One study | None reported | Discontinue only in stable disease |
| Corticosteroids | No | None reported | Only use short periods |
| Thiopurines | No | Controversial | No recommendation |
| Methotrexate | Unclear | None reported | Discontinue in the case of erectile dysfunction |
| Ciclosporine | No | None reported | No recommendation |
| Infliximab | Unclear | None reported | No recommendation |
- Citation: Shin T, Okada H. Infertility in men with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(3): 361-369
- URL: https://www.wjgnet.com/2150-5349/full/v7/i3/361.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i3.361
